601 related articles for article (PubMed ID: 21801067)
1. Expression of matrix metalloproteinase-2 and -9 and membrane-type 1 matrix metalloproteinase in melanocytic tumors of dogs and canine melanoma cell lines.
Docampo MJ; Cabrera J; Rabanal RM; Bassols A
Am J Vet Res; 2011 Aug; 72(8):1087-96. PubMed ID: 21801067
[TBL] [Abstract][Full Text] [Related]
2. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
Hofmann UB; Westphal JR; Zendman AJ; Becker JC; Ruiter DJ; van Muijen GN
J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545
[TBL] [Abstract][Full Text] [Related]
3. Altered expression of versican and hyaluronan in melanocytic tumors of dogs.
Docampo MJ; Rabanal RM; Miquel-Serra L; Hernández D; Domenzain C; Bassols A
Am J Vet Res; 2007 Dec; 68(12):1376-85. PubMed ID: 18052744
[TBL] [Abstract][Full Text] [Related]
4. Expression of matrix metalloproteinase (MMP)-2, MMP-9, MMP-13, and MT1-MMP in skin tumors of human papillomavirus type 8 transgenic mice.
Akgül B; Pfefferle R; Marcuzzi GP; Zigrino P; Krieg T; Pfister H; Mauch C
Exp Dermatol; 2006 Jan; 15(1):35-42. PubMed ID: 16364029
[TBL] [Abstract][Full Text] [Related]
5. Stromal cells as the major source for matrix metalloproteinase-2 in cutaneous melanoma.
Hofmann UB; Eggert AA; Blass K; Bröcker EB; Becker JC
Arch Dermatol Res; 2005 Oct; 297(4):154-60. PubMed ID: 16047212
[TBL] [Abstract][Full Text] [Related]
6. Activity of matrix metalloproteinase-2 (MMP-2) in canine oronasal tumors.
Nakaichi M; Yunuki T; Okuda M; Une S; Taura Y
Res Vet Sci; 2007 Apr; 82(2):271-9. PubMed ID: 17011604
[TBL] [Abstract][Full Text] [Related]
7. Influence of cultured dermal fibroblasts on human melanoma cell proliferation, matrix metalloproteinase-2 (MMP-2) expression and invasion in vitro.
Ntayi C; Hornebeck W; Bernard P
Arch Dermatol Res; 2003 Nov; 295(6):236-41. PubMed ID: 14530987
[TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinases in human melanoma cell lines and xenografts: increased expression of activated matrix metalloproteinase-2 (MMP-2) correlates with melanoma progression.
Hofmann UB; Westphal JR; Waas ET; Zendman AJ; Cornelissen IM; Ruiter DJ; van Muijen GN
Br J Cancer; 1999 Nov; 81(5):774-82. PubMed ID: 10555745
[TBL] [Abstract][Full Text] [Related]
9. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
Sakata K; Shigemasa K; Nagai N; Ohama K
Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of CD44 in canine melanocytic tumours.
Serra M; Rabanal RM; Miquel L; Domenzain C; Bassols A
J Comp Pathol; 2004; 130(2-3):171-80. PubMed ID: 15003475
[TBL] [Abstract][Full Text] [Related]
11. Coordinate expression of membrane type-matrix metalloproteinases-2 and 3 (MT2-MMP and MT3-MMP) and matrix metalloproteinase-2 (MMP-2) in primary and metastatic melanoma cells.
Ohnishi Y; Tajima S; Ishibashi A
Eur J Dermatol; 2001; 11(5):420-3. PubMed ID: 11525948
[TBL] [Abstract][Full Text] [Related]
12. Identification of activated matrix metalloproteinase-2 (MMP-2) as the main gelatinolytic enzyme in malignant melanoma by in situ zymography.
Kurschat P; Wickenhauser C; Groth W; Krieg T; Mauch C
J Pathol; 2002 Jun; 197(2):179-87. PubMed ID: 12015741
[TBL] [Abstract][Full Text] [Related]
13. Enhanced membrane-type 1 matrix metalloproteinase expression by hyaluronan oligosaccharides in breast cancer cells facilitates CD44 cleavage and tumor cell migration.
Kung CI; Chen CY; Yang CC; Lin CY; Chen TH; Wang HS
Oncol Rep; 2012 Nov; 28(5):1808-14. PubMed ID: 22922740
[TBL] [Abstract][Full Text] [Related]
14. Modulation of matrix metalloproteinases by ultraviolet radiation in the canine cornea.
Chandler HL; Kusewitt DF; Colitz CM
Vet Ophthalmol; 2008; 11(3):135-44. PubMed ID: 18435653
[TBL] [Abstract][Full Text] [Related]
15. Expression of matrix metalloprotease-2 (MMP-2) and the activator membrane type 1 (MT1-MMP) in canine mammary carcinomas.
Papparella S; Restucci B; Paciello O; Maiolino P
J Comp Pathol; 2002 May; 126(4):271-6. PubMed ID: 12056775
[TBL] [Abstract][Full Text] [Related]
16. Implication of collagen type I-induced membrane-type 1-matrix metalloproteinase expression and matrix metalloproteinase-2 activation in the metastatic progression of breast carcinoma.
Gilles C; Polette M; Seiki M; Birembaut P; Thompson EW
Lab Invest; 1997 May; 76(5):651-60. PubMed ID: 9166284
[TBL] [Abstract][Full Text] [Related]
17. Differential transcriptional activation of matrix metalloproteinase-2 and membrane type-1 matrix metalloproteinase by experimental deep venous thrombosis and thrombin.
Dahi S; Lee JG; Lovett DH; Sarkar R
J Vasc Surg; 2005 Sep; 42(3):539-45. PubMed ID: 16171603
[TBL] [Abstract][Full Text] [Related]
18. Matrix metalloproteinase-9 expression and release from skin fibroblasts interacting with keratinocytes: Upregulation in response to sulphur mustard.
Ries C; Popp T; Egea V; Kehe K; Jochum M
Toxicology; 2009 Sep; 263(1):26-31. PubMed ID: 18809459
[TBL] [Abstract][Full Text] [Related]
19. Expression of E1AF, an ets-oncogene transcription factor, highly correlates with malignant phenotype of malignant melanoma through up-regulation of the membrane-type-1 matrix metalloproteinase gene.
Hata H; Kitamura T; Higashino F; Hida K; Yoshida K; Ohiro Y; Totsuka Y; Kitagawa Y; Shindoh M
Oncol Rep; 2008 May; 19(5):1093-8. PubMed ID: 18425363
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of membrane-type 1-matrix metalloproteinase (MT1-MMP) production and sequential activation of progelatinase A on human squamous carcinoma cells co-cultured with human dermal fibroblasts.
Sato T; Iwai M; Sakai T; Sato H; Seiki M; Mori Y; Ito A
Br J Cancer; 1999 Jun; 80(8):1137-43. PubMed ID: 10376963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
